A little-known FDA program called "compassionate use" is giving seriously ill people a path to obtaining drugs that are still in testing.

Last year, after having exhausted all other options, nearly 1,200 patients received treatment with experimental drugs for conditions including hepatitis C, cancer and rare diseases like cystic fibrosis, says the US Food and Drug Administration.

(READ the story from the Wall Street Journal)